Novartis To Launch Galvus/Metformin Combo Pill In Europe
This article was originally published in The Pink Sheet Daily
Combination vildagliptin and metformin therapy will be available in the next few weeks, firm says.
You may also be interested in...
EU approves DPP-4 inhibitor with label recommending 50 mg once or twice daily depending on type of combination therapy prescribed.
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.